Infervision Raises $18 Million To Develop Automated Scan Readers

Infervision, a Beijing AI/deep learning company, closed an $18 million B round to advance its automated medical diagnosis products. Founded in 2016, Infervision is developing products that read tomography and X-ray scans to diagnose cancer. The company says its products do not replace radiologists, but help them become more productive. Using Infervision technology, a doctor's time-per-scan could be reduced from ten minutes to five seconds, the company said. Qiming Venture Partners led the B round, joined by Sequoia Capital China and Genesis Capital.